
Currently out of the existing stock ratings of Travis Steed, 50 are a HOLD (29.94%), 105 are a BUY (62.87%), 12 are a SELL (7.19%).
Analyst Travis Steed, currently employed at BAML, has had 62.32% of price targets met with an average potential upside of 19.04%, reached in 244 days on average.
Travis Steed has documented 333 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Financial Services, Communication Services sectors.
Most recent stock forecast was given on AXGN, Axogen at 12-Oct-2026.
Analyst best performing recommendations are on LUNG (PULMONX CORP).
The best stock recommendation documented was for LUNG (PULMONX CORP) on 1/3/2023. The price target of $8 was fulfilled within 1 day with a profit of $0.51 (6.81%), with a performance score of 68.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Jun-2025
$124
$21 (20.39%)
$106
2 days ago
(19-Nov-2026)
Buy Since 29-Jun-2017
$120
$17 (16.50%)
$112
29 days ago
(23-Oct-2026)
25/35 (71.43%)
$16.3 (15.72%)
418
Buy Since 06-Jun-2019
$122
$19 (18.45%)
$112
30 days ago
(22-Oct-2026)
25/33 (75.76%)
$19.49 (19.01%)
420
Buy Since 01-Jul-2026
$123
$20 (19.42%)
$121
30 days ago
(22-Oct-2026)
0/2 (0%)
$20.49 (19.99%)
Buy Since 23-Oct-2018
$118
$15 (14.56%)
$120
30 days ago
(22-Oct-2026)
10/15 (66.67%)
$15.49 (15.11%)
354
Which stock is Travis Steed most bullish on?
Which stock is Travis Steed most reserved on?
What Year was the first public recommendation made by Travis Steed?